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INTRODUCTION
Specific IgE (sIgE) identification is essential for the diagnosis 
and treatment of IgE-mediated allergic diseases, such as aller-
gic rhinitis, asthma, atopic dermatitis, food and drug allergies, 
bee-sting allergy, and anaphylaxis. Allergen avoidance and de-
cisions regarding allergen immunotherapy are based on sIgE 
detection and corresponding symptoms. As the detection of 
sIgE indicates only sensitization, not an allergy itself, both the 
selection of test allergens and the interpretation of test results 
require highly sophisticated judgments. Moreover, when de-
signing test panels, biogeographic characteristics and culinary 
culture should be considered.1,2 As well, clinicians should take 
into account the patient’s age, exposure history with relevant 
manifestations, and allergen cross-reactivity in making deci-
sions regarding the causative allergen(s).3 
Due to the diversity of sIgE detection methods, it is important 
to understand the characteristics (validity, reliability, strengths, 
and limitations) of each test.4 Serologic tests are more conve-
nient than skin tests, since they do not require patients to stop 
medications. Also, in the case of anaphylaxis patients, there is 
no need to wait for recovery of histamine release capability af-
ter a severe anaphylactic reaction. Serologic tests also involve 
no risk of recurrence of allergic reactions due to testing. More-
over, there are no concerns regarding variability associated with 
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the proficiency of the operator, the test site, or underlying medi-
cal illnesses, especially skin diseases.4,5 
In Korea, multiplex sIgE detection is commonly used to 
screen for allergic diseases. In this study, the diagnostic capa-
bility of a new Korean multiplex sIgE assay was compared with 
that of the ImmunoCAP system, which is the current gold-stan-
dard method for allergy diagnosis. 
MATERIALS AND METHODS
Participants
This study was conducted between January 2014 and Decem-
ber 2015 at the Allergy and Asthma Center at Severance Hos-
pital, Yonsei University Health System (Seoul, Korea). Patients 
diagnosed with allergic rhinitis, asthma, atopic dermatitis, food 
allergy, chronic urticarial, or anaphylaxis were enrolled in the 
study. Patients ranging from 6 to 75 years of age were included. 
Patients receiving immunotherapy were excluded. All partici-
pants provided written or verbal informed consent. This study 
was approved by the Institutional Review Board of the Yonsei 
University Health System (Approval no. 1-2014-0068).
Blood sampling
Blood samples were collected from 218 patients using serum 
separation vacuum tubes (Greiner Bio-One, KremsmÜnster, 
Austria). After centrifugation, the serum was collected from 
each sample and stored at -70°C for simultaneous testing. After 
enrollment of the final patient, all samples were sent to two lab-
oratories for sIgE analysis. No accompanying clinical data were 
provided in order to ensure blind testing.
sIgE detection assays 
The ImmunoCAP (Thermo Fisher Scientific, Uppsala, Sweden) 
and AdvanSureTM AlloScreen (LG Life Science, Seoul, Korea) 
assays were compared with respect to sIgE detection. Both tests 
were carried out according to standard instructions provided 
by the respective manufacturers. Thirteen allergens were com-
pared: 10 inhalant allergens [Dermatophagoides pteronyssinus 
(D. pteronyssinus), Dermatophagoides farinae (D. farinae), cat 
and dog dander, Alternaria, birch, oak, ragweed, mugwort, and 
rye grass] and three food allergens (egg white, cow’s milk, pea-
nuts). The cutoff for a positive result for both the ImmunoCAP 
and AlloScreen assays was 0.35 kU/L. Both assays adopted the 
same class determination range, expressed as kU/L: class 0 
(0.00–0.34 kU/L), class 1 (0.35–0.69 kU/L), class 2 (0.70–3.49 kU/L), 
class 3 (3.50–17.49 kU/L), class 4 (17.50–49.99 kU/L), class 5 
(50.00–99.99 kU/L), and class 6 (>100 kU/L).
Statistical analyses
To assess the validity and reliability of the multiplex and single-
plex assays, IBM SPSS Statistics for Windows software, version 
23.0 (IBM Corp., Armonk, NY, USA) was used. First, the sensi-
tivity, specificity, and positive and negative predictive values 
were calculated based on the ImmunoCAP results. The total 
agreement ratio was calculated as follows: (number of both 
tests showing a positive result+number of both tests showing 
a negative result)/total number of tests.6 This agreement was 
analyzed by Pearson’s chi-square test. These categorical cross-
table data were also compared using Cohen’s kappa analysis. 
Kappa values were interpreted as follows: almost perfect (0.8–
1.0), substantial (0.6–0.8), moderate (0.4–0.6), fair (0.2–0.4), and 
poor (<0.2).7 Second, class assessment was compared using 
gamma analysis. The closer the gamma index is to 1 indicates 
stronger association. Third, intra-class correlation (ICC) was 
used for comparison of sIgE titers.8,9 Therein, values closer to 1 
indicate good agreement between the two methods. p<0.05 
indicated statistical significance.
RESULTS
Participants and allergens
A total of 218 patients were enrolled in this study. Their mean 
age was 25.7 years. Males comprised 53.7% of the study group. 
Allergic rhinitis was the most common disease among the pa-
tients (50.9%), followed by asthma, atopic dermatitis, food al-
Table 1. Demographic Characteristics of the Patients
Parameter n=218
Age (yr, mean±SD) 25.73±17.90
Gender, n (%)
Male 117 (53.7)
Female 101 (46.3)
Diagnosis, n (%)
Allergic rhinitis 111 (50.9)
Asthma 65 (29.8)
Atopic dermatitis 70 (32.1)
Food allergy 43 (19.7)
Chronic urticaria 21 (9.6)
Anaphylaxis 5 (2.3)
SD, standard deviation. 
Table 2. Qualitative, Semi-Quantitative, and Quantitative Analyses Used 
for Comparison
Qualitative 
analysis
Semi-quantitative 
analysis
Quantitative analysis
Specific IgE titers
Class
ImmunoCAP
(kUA/L)
AlloScreen
(IU/mL)
Negative 0 <0.35 0.00–0.34
Positive 1 0.35 to <0.7 0.35–0.69
Positive 2 0.7 to <3.5 0.70–3.49
Positive 3 3.5 to <17.5 3.50–17.49
Positive 4 17.5 to <50 17.50–49.99
Positive 5 50 to <100 50.00–99.99
Positive 6 >100 ≥100
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lergy, chronic urticarial, and anaphylaxis (Table 1). The number 
of patients tested for sIgE against each of the 13 allergens and 
the number of patients testing positive for sIgE against each al-
lergen according to the ImmunoCAP assay are shown in Table 2. 
Qualitative comparison: positivity and negativity
Diagnostic agreement between the assays, as determined by 
positivity and negativity, is summarized in Table 3. The total 
agreement ratio ranged from 0.74 (oak) to 0.97 (Alternaria). 
Kappa index classifications were as follows: almost perfect (D. 
pteronyssinus, D. farinae, cat dander, Alternaria), substantial 
(dog dander, birch, mugwort, peanuts), and moderate (oak, rag-
weed, rye grass, egg white, cow’s milk). The kappa indices ranged 
from 0.51 (cow’s milk) to 0.93 (Alternaria). p-values calculated 
using Pearson’s chi-square and Cohen’s kappa analysis were all 
<0.001. 
Semi-quantitative comparison: class consistency 
(class 0–6)
The AlloScreen assay groups test results into classes numbered 
0 to 6. Likewise, the ImmunoCAP assay groups test results for 
both sIgE titers in classes numbered 0 to 6. Even though the two 
systems are fundamentally different, we compared them in 
terms of class determination consistency. The results are shown 
in Table 4. Except for oak allergen, the gamma index of all 
other allergens examined was >0.8. The Spearman’s correlation 
coefficients were >0.7 except for oak, rye grass, and egg white. 
For both indicators, a value close to 1 indicates that the tests are 
in good agreement.
Table 3. Diagnostic Agreement between the Two Assays (Sensitivity and Specificity)
Allergens
Positive patients, n (%) Total agreement
ratio
p value* Kappa index p value†
ImmunoCAP AlloScreen
D. pteronyssinus 37 (53.6) 38 (55.1) 0.93 <0.001 0.85 <0.001
D. farinae 106 (64.6) 109 (66.5) 0.92 <0.001 0.83 <0.001
Cat dander 29 (47.5) 32 (52.5) 0.95 <0.001 0.90 <0.001
Dog dander 35 (50.7) 32 (46.4) 0.87 <0.001 0.74 <0.001
Alternaria 26 (42.6) 24 (39.3) 0.97 <0.001 0.93 <0.001
Birch 40 (57.1) 47 (67.1) 0.81 <0.001 0.61 <0.001
Oak 30 (49.2) 20 (32.8) 0.74 <0.001 0.47 <0.001
Ragweed 38 (52.8) 25 (34.7) 0.79 <0.001 0.59 <0.001
Mugwort 31 (51.7) 20 (33.3) 0.82 <0.001 0.64 <0.001
Rye grass 35 (53.8) 23 (35.4) 0.78 <0.001 0.58 <0.001
Egg white 34 (44.7) 21 (27.6) 0.78 <0.001 0.53 <0.001
Cow’s milk 36 (52.2) 27 (39.1) 0.75 <0.001 0.51 <0.001
Peanuts 31 (51.7) 14 (21.9) 0.87 <0.001 0.74 <0.001
D. farinae, Dermatophagoides farinae; D. pteronyssinus, Dermatophagoides pteronyssinus.
p values were calculated using *Pearson’s chi-square test, †Cohen’s kappa analysis.
Table 4. Class Consistency between the Two Assays
Allergens Gamma index p value
D. pteronyssinus 0.904 <0.001
D. farinae 0.949 <0.001
Cat dander 0.981 <0.001
Dog dander 0.957 <0.001
Alternaria 0.990 <0.001
Birch 0.953 <0.001
Oak 0.644 <0.001
Ragweed 0.911 <0.001
Mugwort 0.935 <0.001
Rye grass 0.819 <0.001
Egg white 0.864 <0.001
Cow’s milk 0.843 <0.001
Peanuts 0.924 <0.001
D. farinae, Dermatophagoides farinae; D. pteronyssinus, Dermatophagoides 
pteronyssinus.
Table 5. Analysis of Correlations between the Two Assays
Allergens Intra-class correlation p value
D. pteronyssinus 0.794 (0.668 to 0.876) <0.001
D. farinae 0.939 (0.918 to 0.956) <0.001
Cat dander 0.813 (0.688 to 0.888) <0.001
Dog dander 0.904 (0.844 to 0.940) <0.001
Alternaria 0.897 (0.828 to 0.938) <0.001
Birch 0.948 (0.917 to 0.968) <0.001
Oak 0.154 (-0.41 to 0.492) 0.260
Ragweed 0.833 (0.733 to 0.896) <0.001
Mugwort 0.394 (-0.02 to 0.638) 0.028
Rye grass 0.556 (0.273 to 0.729) 0.001
Egg white 0.839 (0.747 to 0.898) <0.001
Cow’s milk 0.911 (0.857 to 0.945) <0.001
Peanuts 0.912 (0.852 to 0.947) <0.001
D. pteronyssinus, Dermatophagoides pteronyssinus; D. farinae, Dermatopha-
goides farinae. 
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Quantitative comparison: sIgE titer determination
The ICCs for each allergen are shown in Table 5. The ICCs were 
>0.5 for all of the allergens examined with the exception of oak 
and mugwort. The results of Passing-Bablok regression analy-
ses were not significant. Scatter plots of sIgE titers for each al-
lergen are shown in Fig. 1. In addition, we checked the sIgE ti-
ters of serially diluted serum specimens (Fig. 2). ImmunoCAP 
showed good linearity as a quantitation assay. Despite the limi-
tation of being a semi-quantitation assay, AlloScreen showed 
fair linearity in this dilution test.
DISCUSSION
In this study, we compared the AlloScreen and ImmunoCAP 
assay systems. AlloScreen is a simultaneous test for multiple 
Fig. 1. Specific IgE titers of each allergen detected by ImmunoCAP and AlloScreen. D. pteronyssinus, Dermatophagoides pteronyssinus; D. farinae, Der-
matophagoides farinae.
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Fig. 2. Specific IgE titers of serially diluted serum specimens. Specific IgE titers of Dermatophagoides farinae (D. farina) detected by ImmunoCAP (A) and 
AlloScreen (B). Specific IgE titers of birch detected by ImmunoCAP (C) and AlloScreen (D). Specific IgE titers of dog detected by ImmunoCAP (E) and Al-
loScreen (F).
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allergens that employs a semi-quantitative enzyme immunoas-
say (EIA). There are currently six representative simultaneous 
tests for multiple allergens available in Korea: AdvanSureTM Al-
loScreen (LG Life Science, Seoul, Korea), MAST CLA Allergy Test 
(Hitachi Chemical Diagnostics, Inc., Mountain View, CA, USA), 
Polycheck Allergy (Biocheck GmbH, Munster, Germany), RIDA 
Allergy Screen (R-biopharm, Darmstadt, Germany), PROTIA 
Allergy-Q (ProteomeTech, Seoul, Korea), and RIDA Allergy 
Screen (R-Biopharm, Darmstadt, Germany). AlloScreen can test 
44 to 62 kinds of allergens simultaneously with 3.5 hours of 
analysis time with automation process; required serum amount 
is 100 μL. 
The principal tests mentioned above that are available in 
Korea utilize different technologies, and therefore, the results 
are not necessarily comparable. One difference is the use of 
quantitative fluorescent EIA (ImmunoCAP) versus semi-quan-
titative EIA (AlloScreen).10 The AlloScreen test procedure is as 
follows: each allergen is fixed on a membrane strip in the Allo-
Screen panel. Serum sample (containing IgE) incubation, wash-
ing, incubation with biotinylated anti-IgE, washing, and incu-
bation with streptavidin-alkaline phosphatase and substrate 
proceed sequentially. For color development, nitro-blue tetra-
zolium chloride and 5-bromo-4-chloro-3’-indolyphosphate p-
toluidine salt are utilized, and the resulting signals are analyzed 
using AlloStation equipment. There are also methodological 
differences between the ImmunoCAP and AlloScreen assays 
with respect to allergen coating (covalent binding to a solid phase), 
color development (β-galactosidase and methylumbelliferyl-β-
D-galactoside), and signal detection (fluorescence intensity).11 
For allergen coating, the two assays compared in this study 
utilize different methods, which can lead to differences in IgE 
binding. ImmunoCAP uses multiporous nitrocellulose block, 
which enables thee-dimensional coupling of allergen and its 
IgE. In this process, allergens are attached to the solid phase 
via biotinylation. On the other hand, AlloScreen uses nitrocel-
lulose membrane, which enables two-dimensional coupling 
without modification of allergen.8 
Differences also exist with respect to allergen sources and 
allergenic extract quality control. Mongolian oak (Quercus 
mongolica) and Saw tooth oak (Quercus acutissima) are domi-
nant species in Korea instead of white oak (Quercus alba), 
which is used for ImmunoCAP and AlloScreen.12,13 Well stan-
dardized, commercially available Mongolian oak or Saw tooth 
oak allergen is not available. Therefore, Korean oak allergy pa-
tients are diagnosed using foreign oak tree. In Korean allergy 
patients, the relatively low agreement ratio on oak pollen can 
be explained by the oak allergen used in the test. 
For the above-mentioned reasons, quantitative data regard-
ing sIgE titer are not well correlated. In addition, AlloScreen 
has been developed as a semi-quantitative method, such that 
quantification precision can differ from that in ImmunoCAP. 
Several studies have compared multiplex and single-plex test 
results obtained with various assays. A comparison of the RIDA 
qLine Allergy (R-Biopharm AG, Darmstadt, Germany) and Im-
munoCAP assays revealed that the RIDA system is more likely 
to return false-positive results.14 Another study comparing three 
multiplex sIgE assays [RIDA Allergy Screen (R-Biopharm), 
MAST Optigen allergy system (Hitachi Chemical Diagnostics), 
and Polycheck Allergy (Biocheck GmbH)] showed that the 
MAST Optigen allergy system provides better sensitivity and 
that the Polycheck Allergy provides better specificity.15 The Al-
loScreen was also compared with skin prick test16 and showed 
good correlation and agreement. 
As medical costs and insurance systems differ in each coun-
try, clinicians must be well-informed regarding the strengths 
and weaknesses of available diagnostic assays in terms of their 
use in actual patient testing. The fact that sIgE is detected by 
different assays is not a guarantee that the results are compa-
rable.17 Detection of in vitro sIgE does not mean that it is the 
cause of allergic disease. Clinical manifestation after exposure 
of allergen, cross-reactivity between the allergens should be 
considered for interpretation of sIgE assay.
In order to minimize the disadvantages of in vitro tests, many 
companies have sought to improve the quality of their prod-
ucts.18 The AdvanSureTM AlloScreen is a updated version of the 
AdvanSureTM Allergy Screen.8,19 AlloScreen shows stronger 
agreement with ImmunoCAP than Allergy Screen.8 As these as-
says were developed in an East Asian country, the panel com-
position was differentiated to include Asian sensitization pro-
files: Humulus japonicus as an inhalant allergen, and mackerel 
and chrysalis as food allergens.20,21 
The current study has some limitations. First, this study was 
performed considering sensitization but not a clinical diagno-
sis of allergy, because the clinical relevance of sensitization 
was not considered. Clinical manifestations of allergen expo-
sure in the study subjects were not objectively identified. Sec-
ond, the results of single-plex sIgE assays can differ,6,22,23 al-
though this study compared the AlloScreen assay only with the 
ImmunoCAP assay, as it is highly certified for single-plex sIgE 
detection. Third, false positivity and false negativity of the Allo-
Screen assay were discriminated based on ImmunoCAP test 
results, not clinical manifestation. Finally, the cut-off value for 
sIgE positivity can differ between allergens.11 
In conclusion, the results of the AlloScreen assay correlated 
well with those of the ImmunoCAP assay with regard to com-
mon inhalant and food allergens. However, as each diagnostic 
method has unique characteristics, the results are not neces-
sarily interchangeable.
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